| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Professional Issues Articles
The FDA has received thirty reports of acute pancreatitis (rapid-onset inflammation of the pancreas) in type 2 patients taking Byetta. Twenty-seven of the thirty patients had one or more risk factors for acute pancreatitis, such as gallstones or alcohol use.
In six patients, the pancreatitis symptoms began or worsened after the dose of Byetta was doubled. Twenty-two of the thirty improved after discontinuing Byetta, and three worsened again after Byetta was re-started.
As a result of these reports, the FDA is asking Amylin, the drug's maker, to add a warning about pancreatitis to the "Precautions" section of the drug's label. The agency is advising Byetta-taking patients to seek medical care if they have unexplained persistent abdominal pain, possibly accompanied by vomiting. Physicians are also being instructed to discontinue Byetta if pancreatitis is suspected.
Source: Medpage Today
Categories: Byetta, Medications, Professional Issues, Type 2 Issues, Type 2 Medications
Nov 5, 2007 -
Email to a Friend
Send a link to this page to your friends and colleagues.